VolitionRx collaborates with Sysmex to transfer Nu.Q NETs assay onto Sysmex platform
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets | VNRX Stock News
Yesway Reports Q2 2026 Results: Full Earnings Call Transcript